Toronto Dominion Bank’s Pfizer PFE Stock Holding History

Toronto Dominion Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500,000	Closed	-$12.7M	–	2237
2025 Q3	$12.7M	Buy	+500,000	New	+$12.3M	0.02%	545
2025 Q2	–	Sell	-30,000	Closed	-$760K	–	1949
2025 Q1	$760K	Sell	30,000 -170,000	-85%	-$4.45M	﹤0.01%	1111
2024 Q4	$5.31M	Buy	+200,000	New	+$5.42M	0.01%	695
2023 Q1	–	Sell	-10,000	Closed	-$512K	–	1651
2022 Q4	$512K	Hold	10,000	–	–	﹤0.01%	1136
2022 Q3	$438K	Buy	+10,000	New	+$486K	﹤0.01%	1226
2019 Q2	–	Sell	-24,242	Closed	-$977K	–	1673
2019 Q1	$977K	Sell	24,242 -8,959	-27%	-$359K	﹤0.01%	994
2018 Q4	$1.38M	Sell	33,201 -124,899	-79%	-$5.18M	﹤0.01%	839
2018 Q3	$6.61M	Buy	+158,100	New	+$6.09M	0.01%	618
2016 Q2	–	Sell	-26,350	Closed	-$741K	–	1259
2016 Q1	$741K	Buy	+26,350	New	+$753K	﹤0.01%	319
2015 Q4	–	Sell	-28,669	Closed	-$854K	–	1094
2015 Q3	$854K	Buy	28,669 +7,589	+36%	+$243K	﹤0.01%	372
2015 Q2	$671K	Buy	+21,080	New	+$687K	﹤0.01%	462
2015 Q1	–	Sell	-6,324	Closed	-$187K	–	1090
2014 Q4	$187K	Buy	+6,324	New	+$181K	﹤0.01%	808

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Toronto Dominion Bank's PFE Position: Q2 2026 in Review

Toronto Dominion Bank increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $1.15M and bringing the position to 1,756,923 shares worth $42.3M. The position accounts for 0.05% of the portfolio, ranked #324.

Toronto Dominion Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $419M in Q4 2019. 2,842 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Toronto Dominion Bank held 1,756,923 shares of Pfizer worth $42.3M as of Q2 2026.
Toronto Dominion Bank bought 43,917 Pfizer shares in Q2 2026, an estimated $1.15M.
Pfizer made up 0.05% of Toronto Dominion Bank's portfolio in Q2 2026, its #324 holding.
Toronto Dominion Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Toronto Dominion Bank's Pfizer position peaked at $419M in Q4 2019.
2,842 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.